Treatment of Complicated Pleural Effusions in 2013

Clinics in Chest Medicine

Volumn 34, Issue 1, 2013, Pages 47-62

  Bhatnagar, Rahul ^a   Maskell, Nick A ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Complicated pleural effusions; Empyema; Fibrinolytic therapy; Lung infections; Pleural effusions; Pleural infections

Indexed keywords

ALTEPLASE; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CONTRAST MEDIUM; DEOXYRIBONUCLEASE; GLUCOSE; LACTATE DEHYDROGENASE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PLACEBO; PNEUMOCOCCUS VACCINE; STREPTOKINASE; UROKINASE;

ANTIBIOTIC THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIET SUPPLEMENTATION; ECHOGRAPHY; FIBRINOLYTIC THERAPY; HUMAN; INCIDENCE; MORTALITY; NONHUMAN; PARAPNEUMONIC EFFUSION; PATHOGENESIS; PH; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PLEURAL FIBROSIS; PLEURAL FLUID PH; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; THORACOCENTESIS; THORAX DRAINAGE; THORAX RADIOGRAPHY; THROMBOSIS PREVENTION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADULT; EMPYEMA, PLEURAL; HUMANS; INFECTION; PLEURAL EFFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84873576973     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2012.11.004     Document Type: Review

References (106)

1. Sahn S.A. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis 2007, 45(11):1480-1486.
2. Light R.W. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006, 3(1):75-80.
3. Finley C., Clifton J., Fitzgerald J.M., et al. Empyema: an increasing concern in Canada. Can Respir J 2008, 15(4):219.
4. Farjah F., Symons R.G., Krishnadasan B., et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007, 133(2):346-351.
5. Grijalva C.G., Zhu Y., Nuorti J.P., et al. Emergence of parapneumonic empyema in the USA. Thorax 2011, 66(8):663-668.
6. Davies H.E., Davies R.J., Davies C.W. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010, 65(Suppl 2):ii41-ii53.
7. Breasted J. The Edwin Smith surgical papyrus 1980, University of Chicago Press, Chicago.
8. Hippocrates. Section 5(8). Aphorisms. Available at: Accessed November 28, 2012. http://classics.mit.edu/Hippocrates/aphorisms.5.v.html.
9. Bynum W. The history of medicine: a very short introduction 2008, Oxford University Press, Oxford (United kingdom).
10. Peters R.M. Empyema thoracis: historical perspective. Ann Thorac Surg 1989, 48(2):306-308.
11. Graham E. Some fundamental considerations in the treatment of empyema thoracis 1925, CV Mosby, St Louis (MO).
12. Tobin C.L., Lee Y.C. Pleural infection: what we need to know but don't. Curr Opin Pulm Med 2012, 18(4):321-325.
13. Masson A., Menetrey C., Garnier F., et al. Parapneumonic pleural effusion incidence in a French region before and during the antipneumococcal vaccine era. Arch Pediatr 2011, 18(8):846-849.
14. Goldbart A.D., Leibovitz E., Porat N., et al. Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand J Infect Dis 2009, 41(3):182-187.
15. Wu P.S., Huang L.M., Chang I.S., et al. The epidemiology of hospitalized children with pneumococcal/lobar pneumonia and empyema from 1997 to 2004 in Taiwan. Eur J Pediatr 2010, 169(7):861-866.
16. Taryle D.A., Potts D.E., Sahn S.A. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest 1978, 74(2):170-173.
17. Bartlett J.G., Finegold S.M. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974, 110(1):56-77.
18. Light R.W., Girard W.M., Jenkinson S.G., et al. Parapneumonic effusions. Am J Med 1980, 69(4):507-512.
19. Rahman N.M., Maskell N.A., West A., et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011, 365(6):518-526.
20. Bender J.M., Ampofo K., Sheng X., et al. Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis 2009, 15(1):44-48.
21. Ferguson A.D., Prescott R.J., Selkon J.B., et al. The clinical course and management of thoracic empyema. QJM 1996, 89(4):285-289.
22. Tu C.Y., Hsu W.H., Hsia T.C., et al. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 2006, 32(4):570-576.
23. Wilkosz S., Edwards L.A., Bielsa S., et al. Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2012, 46(2):180-187.
24. Community acquired pneumonia 2001, Plenum Press, New York. T.J. Marrie (Ed.).
25. Whiley R.A., Beighton D., Winstanley T.G., et al. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992, 30(1):243-244.
26. Chalmers J.D., Singanayagam A., Murray M.P., et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009, 64(7):592-597.
27. Heffner J.E. Diagnosis and management of thoracic empyemas. Curr Opin Pulm Med 1996, 2(3):198-205.
28. Becker A., Amantea S.L., Fraga J.C., et al. Impact of antibiotic therapy on laboratory analysis of parapneumonic pleural fluid in children. J Pediatr Surg 2011, 46(3):452-457.
29. Menzies S.M., Rahman N.M., Wrightson J.M., et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011, 66(8):658-662.
30. Ferrer A., Osset J., Alegre J., et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 1999, 18(4):237-241.
31. Maskell N.A., Batt S., Hedley E.L., et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006, 174(7):817-823.
32. Bartlett J.G., Thadepalli H., Gorbach S.L., et al. Bacteriology of empyema. Lancet 1974, 303(7853):338-340.
33. Lisboa T., Waterer G.W., Lee Y.C. Pleural infection: changing bacteriology and its implications. Respirology 2011, 16(4):598-603.
34. Hendrickson D.J., Blumberg D.A., Joad J.P., et al. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008, 27(11):1030-1032.
35. Koegelenberg C.F., Diacon A.H., Bolliger C.T. Parapneumonic pleural effusion and empyema. Respiration 2008, 75(3):241-250.
36. Porcel J.M. Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med 2010, 16(4):357-361.
37. Idell S. The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med 2008, 14(4):310-315.
38. Noppen M., De Waele M., Li R., et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 2000, 162(3 Pt 1):1023-1026.
39. Kroegel C., Antony V.B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997, 10(10):2411-2418.
40. Pine J.R., Hollman J.L. Elevated pleural fluid pH in Proteus mirabilis empyema. Chest 1983, 84(1):109-111.
41. Idell S., Girard W., Koenig K.B., et al. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991, 144(1):187-194.
42. Philip-Joët F., Alessi M.C., Philip-Joët C., et al. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995, 8(8):1352-1356.
43. Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991, 88(4):1067-1072.
44. Idell S., Pendurthi U., Pueblitz S., et al. Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thromb Haemost 1998, 79(3):649-655.
45. Idell S., Mazar A., Cines D., et al. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med 2002, 166(7):920-926.
46. Strange C., Baumann M.H., Sahn S.A., et al. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 1995, 151(2 Pt 1):508-515.
47. Sharma J.K., Marrie T.J. Explosive pleuritis. Can J Infect Dis 2001, 12(2):104-107.
48. Lim W.S., Baudouin S.V., George R.C., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl 3):iii1-iii55.
49. Sahn S.A., Light R.W. The sun should never set on a parapneumonic effusion. Chest 1989, 95(5):945-947.
50. Torres A., Menéndez R. Mortality in COPD patients with community-acquired pneumonia: who is the third partner?. Eur Respir J 2006, 28(2):262-263.
51. Maskell N.A., Kahan B.C., Rahman N.M. Rapid score - the first validated clinical score in pleural infection to identify those at risk of poor. Am J Respir Crit Care Med 2012, 185:A5431.
52. de Lacey G., Morley S., Berman L. The chest X-ray: a survival guide 2008, Saunders Elsevier, Philadelphia.
53. Heffner J.E., Klein J.S., Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest 2010, 137(2):467-479.
54. Lamont T., Surkitt-Parr M., Scarpello J., et al. Insertion of chest drains: summary of a safety report from the National Patient Safety Agency. BMJ 2009, 339:b4923.
55. Diacon A.H., Brutsche M.H., Solèr M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest 2003, 123(2):436-441.
56. Ravenel J.G., McAdams H.P. Multiplanar and three-dimensional imaging of the thorax. Radiol Clin North Am 2003, 41(3):475-489.
57. Evans A.L., Gleeson F.V. Radiology in pleural disease: state of the art. Respirology 2004, 9(3):300-312.
58. Aquino S.L., Webb W.R., Gushiken B.J. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994, 192(3):803-808.
59. Chen K.Y., Liaw Y.S., Wang H.C., et al. Sonographic septation: a useful prognostic indicator of acute thoracic empyema. J Ultrasound Med 2000, 19(12):837-843.
60. Gervais D.A., Levis D.A., Hahn P.F., et al. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology 2008, 246(3):956-963.
61. Roberts J.R. Minimally invasive surgery in the treatment of empyema: intraoperative decision making. Ann Thorac Surg 2003, 76(1):225-230. [discussion: 229-30].
62. Toaff J.S., Metser U., Gottfried M., et al. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography. Invest Radiol 2005, 40(4):204-209.
63. Skouras V., Awdankiewicz A., Light R.W. What size parapneumonic effusions should be sampled?. Thorax 2010, 65(1):91.
64. Hooper C., Lee Y.C., Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010, 65(Suppl 2):ii4-ii17.
65. Porcel J.M. Pearls and myths in pleural fluid analysis. Respirology 2011, 16(1):44-52.
66. Heffner J.E., Brown K., Barbieri C., et al. Clinical commentary pleural fluid chemical analysis in parapneumonic effusions. Am J Respir Crit Care Med 1995, 151(6):1700-1708.
67. Rahman N.M., Mishra E.K., Davies H.E., et al. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med 2008, 178(5):483-490.
68. Manuel Porcel J., Vives M., Esquerda A., et al. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions. Respir Med 2006, 100(5):933-937.
69. Vives M., Porcel J.M., Gázquez I., et al. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions. Respiration 2000, 67(4):433-438.
70. Alegre J., Jufresa J., Segura R., et al. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions. Eur Respir J 2002, 19(2):320-325.
71. Lin M.C., Chen Y.C., Wu J.T., et al. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest 2009, 136(1):205-211.
72. San Jose M.E., Valdes L., Vizcaino L.H., et al. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions. J Investig Med 2010, 58(8):971-976.
73. Porcel J.M., Vives M., Cao G., et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009, 34(6):1383-1389.
74. Tsilioni I., Kostikas K., Kalomenidis I., et al. Diagnostic accuracy of biomarkers of oxidative stress in parapneumonic pleural effusions. Eur J Clin Invest 2011, 41(4):349-356.
75. Porcel J.M., Vives M., Esquerda A. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest 2004, 125(1):160-164.
76. Porcel J.M., Galindo C., Esquerda A., et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology 2008, 13(1):58-62.
77. San Jose M.E., Valdes L., Gonzalez-Barcala F.J., et al. Diagnostic value of proinflammatory interleukins in parapneumonic effusions. Am J Clin Pathol 2010, 133(6):884-891.
78. Skouras V., Boultadakis E., Nikoulis D., et al. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology 2012, 17(2):308-314.
79. Papaioannou A.I., Kostikas K., Tsopa P., et al. Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions. Respiration 2010, 80(6):472-479.
80. Hill J., Treasure T. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 2010, 340:c95.
81. Taryle D.A., Good J.T., Morgan E.J., et al. Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother 1981, 7(2):171-177.
82. Teixeira L.R., Sasse S.A., Villarino M.A., et al. Antibiotic levels in empyemic pleural fluid. Chest 2000, 117(6):1734-1739.
83. Thys J.P., Vanderhoeft P., Herchuelz A., et al. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest 1988, 93(3):530-532.
84. Shohet I., Yellin A., Meyerovitch J., et al. Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model. Antimicrob Agents Chemother 1987, 31(7):982-985.
85. Liu Y.H., Lin Y.C., Liang S.J., et al. Ultrasound-guided pigtail catheters for drainage of various pleural diseases. Am J Emerg Med 2010, 28(8):915-921.
86. Rahman N.M., Maskell N.A., Davies C.W., et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010, 137(3):536-543.
87. Light R.W. Pleural controversy: optimal chest tube size for drainage. Respirology 2011, 16(2):244-248.
88. Ng T., Ryder B.A., Maziak D.E., et al. Treatment of postpneumonectomy empyema with debridement followed by continuous antibiotic irrigation. J Am Coll Surg 2008, 206(3):1178-1183.
89. Sherry S., Johnson A., Tillett W.S. The action of streptococcal desoxyribose nuclease (streptodornase) in vitro and on purulent pleural exudations of patients. J Clin Invest 1949, 28(5 Pt 2):1094-1104.
90. Davies R.J., Traill Z.C., Gleeson F.V. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997, 52(5):416-421.
91. Bouros D., Schiza S., Tzanakis N., et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999, 159(1):37-42.
92. Tuncozgur B., Ustunsoy H., Sivrikoz M.C., et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 2001, 55(10):658-660.
93. Diacon A.H., Koegelenberg C.F., Bolliger C.T. A trial of intrapleural streptokinase. N Engl J Med 2005, 352(21):2243-2245. [author reply: 2243-5].
94. Maskell N.A., Davies C.W., Nunn A.J., et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005, 352(9):865-874.
95. Cameron R., Davies H.R. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2008, (2). CD002312.
96. Heffner J.E. Multicenter trials of treatment for empyema - after all these years. N Engl J Med 2005, 352(9):926-928.
97. Young K.C., Shi G.Y., Wu D.H., et al. Plasminogen activation by streptokinase via a unique mechanism. J Biol Chem 1998, 273(5):3110-3116.
98. Zhu Z., Hawthorne M.L., Guo Y., et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006, 129(6):1577-1583.
99. Janda S., Swiston J. Intra-pleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest 2012, 142:401-411.
100. Shah S.S., Ten Have T.R., Metlay J.P. Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement. Pediatr Pulmonol 2010, 45(1):71-77.
101. Yamaguchi M., Takeo S., Suemitsu R., et al. Video-assisted thoracic surgery for fibropurulent thoracic empyema: a bridge to open thoracic surgery. Ann Thorac Cardiovasc Surg 2009, 15(6):368-372.
102. Luh S.P., Chou M.C., Wang L.S., et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest 2005, 127(4):1427-1432.
103. Chambers A., Routledge T., Dunning J., et al. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema?. Interact Cardiovasc Thorac Surg 2010, 11(2):171-177.
104. Molnar T.F. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg 2007, 32(3):422-430.
105. Angelillo Mackinlay T.A., Lyons G.A., Chimondeguy D.J., et al. VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema. Ann Thorac Surg 1996, 61(6):1626-1630.
106. Zahid I., Nagendran M., Routledge T., et al. Comparison of video-assisted thoracoscopic surgery and open surgery in the management of primary empyema. Curr Opin Pulm Med 2011, 17(4):255-259.